IMPACT OF ANESTHESIA WITH PROLONGED USE OF DESFLURANE AND SEVOFLURANE ON THE CARDIAC FUNCTION IN CORONARY ARTERY BYPASS GRAFT SURGERIES WITH CARDIOPULMONARY BYPASS

Goal of the study: to assess the feasibility of using inhalation anesthetics of desflurane and sevoflurane during cardiopulmonary bypass to reduce the chances of post-perfusion cardiac dysfunction during myocardial revasculization surgeries. Materials and methods: 75 patients suffering from coronary disease and undergoing myocardial revasculization with cardiopulmonary bypass were divided into three groups as per the type of used anesthetic: Group 1 receiving desflurane (n = 30), Group 2 receiving sevoflurane (n = 28) and Group 3 receiving propofol (n = 17). Anesthetics were used at all stages of anesthesia including cardiopulmonary bypass. The rates of the wider hemodynamic profile were registered (cardiac index, systolic output index, index of peripheral resistance and pulmonary vessels resistance, index of systolic output of the left and right ventricles, pulmonary capillary wedge pressure). During cardiopulmonary bypass the blood was collected from cardiac coronary sinus in order to assess changes in the levels of lactate and pyruvate before aortic compression, before the release of clamps and in 30 minutes of reperfusion. During the first 24 hours of the post-perfusion period, the following parameters were assessed: frequency of post-perfusion cardiac failure development, duration of artificial pulmonary ventilation and stay in the intensive care department. The level of troponin I was tested in 12 and 24 hours. Results. The hemodynamic profile, blood levels of lactate and pyruvate during cardiopulmonary bypass did not differ between the groups. The rate of increase of the levels of the above metabolites by the 30th minute of reperfusion was the same for all the groups; lactate-pyruvate ratio was stable during all time of anesthesia. There were no differences in the post-operative level of troponin I between the groups during the first 12 and 24 hours after the surgery. The frequency of post-perfusion cardiac failure and its course were similar for all group. Conclusion. Prolonged administration of inhalation anesthetics during cardiopulmonary bypass does not protect myocardium from ischemic and reperfusion lesions.

1. Vislobokov А.I., Zvartau E.E., Polushin Yu.S., Аlferova V.V., Bukhankov I.G. Changes in intracellular potentials and ion fluxes of neurons of mollusks by extracellular and intracellular action of sevoflurane and desflurane. Vestn. Anesteziologii I Reanimatologii, 2015, no. 2, pp. 65-75. (In Russ.)

2. Vislobokov А.I., Polushin Yu.S., Polushin А.Yu., Аlferova V.V. Changes of electrophysiological properties of neurons caused by sevoflurane and their role in pre-conditioning and cytoprotection mechanisms. Vestn. Anesteziologii I Reanimatologii, 2015, no. 3, pp. 19-27. (In Russ.)

3. Likhvantsev V.V., Grebennikov O.А., Filippovskaya Zh.S., Lopatin А.F., Cherpakov R.А., Skripkin Yu.V. Anesthetic pre-conditioning: definition, implementation mechanism, clinical value. Vestn. Intensivnoy Terapii, 2014, no. 4, pp. 55-59. (In Russ.)

4. Khatinskiy А.S., Fursov А.А., Bigashev R.B., Linev K.А., Gritsan А.I. Use of sevoflurane during cardiopulmonary bypass under normothermia. Sibirskoye Med. Obozreniye, 2010, no. 2, pp. 81-84. (In Russ.)

5. de Hert S.G.,Vlasselaers D., Barbé R. et al. A comparison of volatile and nonvolatile agents for cardioprotection during on-pump coronary surgery. Anaesthesia, 2009, vol. 64, pp. 953-960.

6. Doenst T., Borger M.A., Weisel R.D., Yau T.M., Maganti M., RaoV. Relation between aortic cross-clamp time and mortality - not as straightforward as expected. Eur. J. Cardiothoracic Surg., 2008, vol. 33, no. 4, pp. 660-665.

7. Landoni G, Biondi-Zoccai G.G.L., Zangrillo A. et al. Desflurane and sevoflurane in cardiac surgery: a meta-analysis of randomized clinical trials. JCVA, 2007, vol. 21, pp. 502-511.

8. Landoni G., Guarracino F., Cariello C., Franco A., Baldassarri R. et al. Volatile compared with total intravenous anesthesia in patients undergoing high-risk cardiac surgery: a randomized multicentre study. Br. J. Anaesth., 2014, vol. 113, no. 6, pp. 955-963.

9. McMullan V., Alston R.P., Tyrrell J. Volatile anaesthesia during cardiopulmonary bypass. Perfusion, 2015, vol. 30, no. 1, pp. 6-16.

10. Vinten-Johansen J., Nakanishi K. Postcardioplegia acute cardiac dysfunction and reperfusion injury. J. Cardiothorac. Vasc. Anesth., 1993, vol. 7, no. 4, suppl. 2, pp. 6-18.